Cam Gallagher

Chief Business Officer

Cam Gallagher currently serves as chief business officer of Zavante Therapeutics. He has more than 20 years of experience in operations, strategy and the financing of both private and public companies, and serves as the sole managing director of Nerveda, LLC, a life science seed fund he co-founded in June 2007. He recently served as a director at Retrosense Therapeutics, a privately held gene therapy company focused on optogenetics through its acquisition by Allergan. He served as chairman of the board of directors of DioGenix, a privately held molecular diagnostic company, from 2009 to 2014, and as a director at Sorrento Therapeutics, a publicly held monoclonal antibody company with a focus on oncology from 2012 to 2014. Gallagher previously served in various senior marketing positions of increasing responsibility at Verus Pharmaceuticals, a privately held specialty pharmaceutical company in San Diego, and in positions of increasing management responsibilities at CV Therapeutics and Dura Pharmaceuticals. Gallagher holds a master’s degree in business from the University of San Diego and a bachelor’s degree in business administration from The Ohio University.